Dignover

Categorie

Dignover Les marques, Dignover Analogs

Dignover Les marques melange

Tarka (trandolapril + verapamil hydrochloride)

Dignover Formule chimique

C₂₇H₃₈N₂O₄

Dignover RX lien

http://www.rxlist.com/cgi/generic/verapsr.htm

Dignover FDA fiche

Dignover FDA

Dignover msds (fiche de securite des materiaux)

Dignover Synthese de reference

Dengel, le brevet américain. 3,261,859 (1966)

Dignover Poids moleculaire

454.602 g/mol

Dignover Point de fusion

< 25 ^oC

Dignover H₂O Solubilite

4,47 mg / L

Dignover Etat

Liquid

Dignover LogP

5.931

Dignover Formes pharmaceutiques

Capsule (libération prolongée); liquide; Solution; Tablet; Tablet (libération prolongée)

Dignover Indication

Pour le traitement de l'hypertension et l'angine.

Dignover Pharmacologie

Vérapamil, un anti-arythmique de classe IV agent, est utilisé comme un blocage des canaux calciques (BCC) agent pour le traitement de l'angine, l'hypertension, et pour tachyarythmies supraventriculaires.

Dignover Absorption

90%

Dignover Toxicite

DL50 = 8 mg / kg (iv chez la souris)

Dignover Information pour les patients

Verapamil HCl is known as a calcium channel blocker. It is taken to treat high blood pressure, to relieve some chest pains in patients with angina, or to treat some problems with heart rhythms. Verapamil has several drug interactions, make sure your physician and pharmacist known all the medicines you are taking so they may properly advise you. Verapamil HCl is excreted in breast milk. It may be necessary to change therapy or provide an alternate to breast milk. The most common side effect is constipation. This may be relieved with dietary modification (more fiber) or laxatives. Sustained release tablets should be taken with food. They should not be broken or crushed. Doses may need some adjustment, make sure to have your condition monitored regularly.

Dignover Organismes affectes

Les humains et autres mammifères